Side effects Because retatrutide stimulates GLP-1 receptors, the side effects are broadly similar to current GLP-1 medicines
Developed by Eli Lilly, retatrutide simultaneously activates GLP-1, GIP, and glucagon receptors a mechanism that may offer advantages for weight management, metabolic health, and conditions such as polycystic ovary syndrome (PCOS) that disproportionately affect women
Alpha lipoic acid and vitamins C and E directly recycle and extends the lifespan of glutathione cleaning the molecule of any freeradicals, toxins, and heavy metals that they might have grabbed
For many patients, it offers a safe, reversible, and highly effective path to better health
This results in: Slowing down digestion Encouraging the release of insulin after eating Lowering the amount of glucagon (sugar) that gets released after eating Sending satiety (fullness) signals to your brain Together, these effects help control blood sugar and promote weight loss
No insurance is required, and HSA/FSA accounts cover the medication